S. Niraula, G. Pond, R. de Wit, M. Eisenberger, I. F. Tannock, and A. M. Joshua, “Influence of concurrent medications on outcomes of men with prostate cancer included in the TAX 327 study”, CUAJ, vol. 7, no. 1-2, pp. E74–81, Feb. 2013.